Biocytogen will be attending the Festival of Biologics from September 30th-October 2nd in Basel, Switzerland! With over 3,000 global attendees and 350 expert speakers, engage in speaker sessions, countless topics of interest and over 150 exhibitors of leading solution providers. Visit us at Booth #632 to connect with our team and discover our latest advancements in human antibody development and preclinical research. This conference is packed with scientific innovation and opportunities for strategic collaboration. We look forward to seeing you there!
What is FOB Basel 2025?
The Festival of Biologics (FOB) is a premier event for biologics and advanced therapies, bringing together 3,000+ global attendees and 350 expert speakers. Covering antibody therapies, cell and gene therapies, immunotherapies, and biosimilars, it offers insights across discovery, development, clinical trials, manufacturing, and commercialization. Designed for pharma, biotech, start-ups, academia, regulators, and investors, it is the key place for the latest in biologics and ATMP innovation.
Event Overview
Date: Sep. 30th - Oct. 2nd, 2025
Venue: Hall 1, Messe Basel. Messeplatz 10, 4058 Basel, Switzerland
Event Schedule
For a more in-depth overview of the agenda, please refer to Festival of Biologics Agenda
About BIOCYTOGEN
Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).
We look forward to seeing you at the FOB in Basel, Switzerland!
